HCW Biologics Inc
NASDAQ:HCWB

Watchlist Manager
HCW Biologics Inc Logo
HCW Biologics Inc
NASDAQ:HCWB
Watchlist
Price: 1.12 USD 15.39% Market Closed
Market Cap: 3m USD

Relative Value

The Relative Value of one HCWB stock under the Base Case scenario is hidden USD. Compared to the current market price of 1.12 USD, HCW Biologics Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HCWB Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
69
vs Industry
67
Median 3Y
10.6
Median 5Y
14.1
Industry
8
Forward
0.4
vs History
vs Industry
Median 3Y
-0.7
Median 5Y
-2.5
Industry
23.5
Forward
-0.2
vs History
vs Industry
Median 3Y
-1.4
Median 5Y
-2.7
Industry
21.9
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-2.2
Industry
24.3
vs History
vs Industry
34
Median 3Y
-1
Median 5Y
1.7
Industry
3.2
vs History
9
vs Industry
42
Median 3Y
14.3
Median 5Y
14.1
Industry
8.1
Forward
1.4
vs History
5
vs Industry
23
Median 3Y
62.8
Median 5Y
30.1
Industry
10.1
vs History
vs Industry
Median 3Y
-1.7
Median 5Y
-2
Industry
5.9
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-1.9
Industry
6.2
Forward
-1.6
vs History
vs Industry
Median 3Y
-2
Median 5Y
-2.4
Industry
7.7
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-1.9
Industry
6.3
vs History
90
vs Industry
21
Median 3Y
3
Median 5Y
3
Industry
5.6

Multiples Across Competitors

HCWB Competitors Multiples
HCW Biologics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
HCW Biologics Inc
NASDAQ:HCWB
2.9m USD 6.9 -0.1 -1 -0.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 837 682.7 -160 825.5 -195 293.4 -193 064.9
US
Abbvie Inc
NYSE:ABBV
389.1B USD 6.5 165.7 16.1 22.8
US
Amgen Inc
NASDAQ:AMGN
172B USD 4.8 24.6 17.8 17.8
US
Gilead Sciences Inc
NASDAQ:GILD
145.7B USD 5 18 12 12
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113.1B USD 9.6 30.8 22.5 23.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 082 -531.3 -578.5 -563.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.9B USD 5.6 17.4 16.6 18.8
AU
CSL Ltd
ASX:CSL
83.5B AUD 3.6 18.6 12.6 15.7
NL
argenx SE
XBRU:ARGX
44.1B EUR 14.3 33.7 58.1 59.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
51.4B USD 16 1 180.3 159.1 193
P/E Multiple
Earnings Growth PEG
US
HCW Biologics Inc
NASDAQ:HCWB
Average P/E: 186.1
Negative Multiple: -0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 825.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
165.7
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.6
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.8
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.4
10%
1.7
AU
CSL Ltd
ASX:CSL
18.6
11%
1.7
NL
argenx SE
XBRU:ARGX
33.7
40%
0.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 180.3
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
HCW Biologics Inc
NASDAQ:HCWB
Average EV/EBITDA: 39.4
Negative Multiple: -1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 293.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.1
14%
1.1
US
Amgen Inc
NASDAQ:AMGN
17.8
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12
7%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.5
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -578.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.6
11%
1.5
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
NL
argenx SE
XBRU:ARGX
58.1
810%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
159.1
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
HCW Biologics Inc
NASDAQ:HCWB
Average EV/EBIT: 45.4
Negative Multiple: -0.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 064.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.8
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.8
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.1 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.8
13%
1.4
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
NL
argenx SE
XBRU:ARGX
59.7
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
193
N/A N/A